MyoKardia Announces Proposed Public Offering of Common Stock
26 sept. 2016 16h48 HE
|
MyoKardia, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2016 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach for the treatment...